These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 10077159)
1. Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens. Pouliot F; Labrie C Int J Cancer; 1999 Mar; 81(1):98-103. PubMed ID: 10077159 [TBL] [Abstract][Full Text] [Related]
2. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC; de Caestecker MP; Schnaper HW Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488 [TBL] [Abstract][Full Text] [Related]
3. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. Xie W; Mertens JC; Reiss DJ; Rimm DL; Camp RL; Haffty BG; Reiss M Cancer Res; 2002 Jan; 62(2):497-505. PubMed ID: 11809701 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154 [TBL] [Abstract][Full Text] [Related]
5. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283 [TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD. Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945 [TBL] [Abstract][Full Text] [Related]
7. Smads in human trophoblast cells: expression, regulation and role in TGF-beta-induced transcriptional activity. Wu D; Luo S; Wang Y; Zhuang L; Chen Y; Peng C Mol Cell Endocrinol; 2001 Apr; 175(1-2):111-21. PubMed ID: 11325521 [TBL] [Abstract][Full Text] [Related]
8. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Kjellman C; Olofsson SP; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford LG; Sjögren HO; Widegren B Int J Cancer; 2000 May; 89(3):251-8. PubMed ID: 10861501 [TBL] [Abstract][Full Text] [Related]
9. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines. Fink SP; Mikkola D; Willson JK; Markowitz S Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756 [TBL] [Abstract][Full Text] [Related]
10. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor. Fanayan S; Firth SM; Butt AJ; Baxter RC J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells. Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629 [TBL] [Abstract][Full Text] [Related]
13. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3. Chipuk JE; Cornelius SC; Pultz NJ; Jorgensen JS; Bonham MJ; Kim SJ; Danielpour D J Biol Chem; 2002 Jan; 277(2):1240-8. PubMed ID: 11707452 [TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-beta in the SiHa human cervical carcinoma cell line. Lee S; Cho YS; Shim C; Kim J; Choi J; Oh S; Kim J; Zhang W; Lee J Int J Cancer; 2001 Nov; 94(4):500-7. PubMed ID: 11745435 [TBL] [Abstract][Full Text] [Related]
15. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995 [TBL] [Abstract][Full Text] [Related]
16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
17. Expression of transforming-growth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-beta1. Piek E; Westermark U; Kastemar M; Heldin CH; van Zoelen EJ; Nistér M; Ten Dijke P Int J Cancer; 1999 Mar; 80(5):756-63. PubMed ID: 10048979 [TBL] [Abstract][Full Text] [Related]
18. Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells. Kelley TJ; Elmer HL; Corey DA Am J Respir Cell Mol Biol; 2001 Dec; 25(6):732-8. PubMed ID: 11726399 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of PAI-1 is mediated through TGF-beta/Smad pathway in transplant arteriopathy. Dong C; Zhu S; Wang T; Yoon W; Goldschmidt-Clermont PJ J Heart Lung Transplant; 2002 Sep; 21(9):999-1008. PubMed ID: 12231371 [TBL] [Abstract][Full Text] [Related]
20. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line. He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]